Possibilities of Continuous Glucose Monitoring System Use in Diabetes Mellitus Type 1

Main Article Content

T.V. Mokhort
Ye.S. Makhlina
M.A. Mashkova

Abstract

No abstract

Article Details

How to Cite
Mokhort, T., Y. Makhlina, and M. Mashkova. “Possibilities of Continuous Glucose Monitoring System Use in Diabetes Mellitus Type 1”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), no. 1.41, Feb. 2012, pp. 43-48, doi:10.22141/2224-0721.0.1.41.2012.176810.
Section
To practicing Endocrinologists

References

Махлина Е.С. Индекс риска дисгликемии — предиктор скрытых гипогликемических реакций // Мат-лы Международной научно-практической конференции «Чернобыльские чтения — 2010», Гомель, 15–16 апреля 2010 г. — Гомель, 2010. — С. 162-163.

Bragd J. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? / Bragd J., Adamson U., Backlund L.B., Lins P.E., Moberg E., Oskarsson P. // Diabetes Metab. — 2008. — Vol. 34. — P. 612-616.

Daneman D. Type 1 diabetes / D. Daneman // Lancet. — 2006. — Vol. 367. — Р. 847-858.

DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complicatsons in snsulini-dependent diabetes mellitus // N. Engl. J. Med. — 1993. — Vol. 329. — Р. 977-986.

DCCT Research Group. The relationship of glycemic exposure (HBA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial // Diabetes. — 1995. — Vol. 44. — Р. 968-983.

Jones S.C. Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells / Jones S.C., Saunders H.J., Qi W., Pollock C.A. // Diabetologia. — 1999. — Vol. 42. — P. 1113-1119.

Kovatchev B.P. Symmetrization of the blood glucose measurement scale and its applications / Kovatchev B.P., Cox D.J., Gonder-Frederick L.A., Clarke W. // Diabetes Care. — 1997. — Vol. 20. — P. 1655-1658.

Kovatchev B.P. Evaluation of a new measure of blood glucose variability in diabetes / Kovatchev B.P., Otto E., Cox D., Gonder-Frederick L., Clarke W. // Diabetes Care. — 2006. — Vol. 29. — P. 2433-2438.

Makhlina Е., Mokhort T. Risk Estimation of Hypoglycemic Reactions among Patients with Type 1 Diabetes Mellitus // 12th European Congress of Endocrinology, Prague, Czech Republic, 24–28 apr. 2010. — Prague, 2010. — P. 282.

Ohkubo Y. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study // Diabetes Res. Clin. Pract. — 1995. — Vol. 28, № 2. — Р. 103-117.

Rury R. et al. UKPDS 80: 10-year follow-up of intensive glucose control in type 2 diabetes // N. Engl. J. Med. — 2008. — Vol. 359. — Р. 1577-1589.

Stettler C. et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials // Am. Heart. J. — 2006. — Vol. 152, № 1. — Р. 27-38.

Takeuchi A. Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells / Takeuchi A., Throckmorton D.C., Brogden A.P., Yoshizawa N., Rasmussen H., Kashgarian M. //Am. J. Physiol. — 1995. — Vol. 268. — P. 13-19.

Most read articles by the same author(s)